As highly effective anti-obesity therapies emerge and regulatory expectations evolve, sponsors are adopting innovative trial designs, addressing long-term weight maintenance, monitoring lean mass ...
Explore how AI can optimize study design, speed patient recruitment, and streamline operational workflows to shorten ...
In today’s ACT Brief, we break down FDA’s new superiority requirement reshaping CAR-T development, examine Pfizer’s global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback